These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1069553)

  • 1. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.
    Cunningham TJ; Antemann R; Paonessa D; Sponzo RW; Steiner D
    Ann N Y Acad Sci; 1976; 277(00):339-44. PubMed ID: 1069553
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer.
    Papac R; Minor DR; Rudnick S; Solomon LR; Capizzi RL
    Cancer Res; 1978 Oct; 38(10):3150-3. PubMed ID: 356962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Albright L; Madigan JC; Gaston MR; Houchens DP
    Cancer Res; 1975 Mar; 35(3):658-65. PubMed ID: 234790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunotherapy of advanced human cancer with neuraminidase.
    Ngu VA; Osunkoya BO; Ajayi OO; Khwaja MS
    Niger Med J; 1973 Jan; 3(1):15-9. PubMed ID: 4805217
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic sarcoma. Combined surgical and immunotherapeutic approach. Neuraminidase treated tumor cells as tumor vaccine.
    Gunnarsson A; McKhann CF; Simmons RL; Grage TB
    Minn Med; 1974 Jul; 57(7):558-61. PubMed ID: 4845897
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ
    Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
    Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 12. Melbourne trial of adjuvant immunotherapy in operable large bowel cancer.
    Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
    Aust N Z J Surg; 1988 Jan; 58(1):43-6. PubMed ID: 3046593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and chemotherapy in children with neuroblastoma.
    Nesbit ME; Kersey J; Finklestein J; Weiner J; Simmons R
    J Natl Cancer Inst; 1976 Sep; 57(3):717-20. PubMed ID: 978774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck.
    Donaldson RC
    Am J Surg; 1972 Oct; 124(4):527-34. PubMed ID: 5076168
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
    Suen JY; Richman SP; Livingston RB; Hersh EM; Craig R; Tonymon K
    Am J Surg; 1977 Oct; 134(4):474-8. PubMed ID: 911030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
    Pinsky CM; Hirshaut Y; Wanebo HJ; Fortner JG; Miké V; Schottenfeld D; Oettgen HF
    Ann N Y Acad Sci; 1976; 277(00):187-94. PubMed ID: 1069548
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV; McKhann CF; Grage TB; Gunnarsson A; Simmons RL
    Cancer; 1979 Apr; 43(4):1297-303. PubMed ID: 445331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 20. Active specific immunotherapy of human colorectal carcinoma with an autologous tumor cell/bacillus Calmette-Guérin vaccine.
    Hanna MG; Ransom JH; Pomato N; Peters L; Bloemena E; Vermorken JB; Hoover HC
    Ann N Y Acad Sci; 1993 Aug; 690():135-46. PubMed ID: 8368732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.